Cat. No. 1998
Biological ActivityPotent, metabolically stable neurotensin receptor agonist peptide (IC50 = 0.15 nM for inhibition of [125I]-NT binding to neonatal mouse brain; EC50 = 1.9 nM for contraction of guinea pig ileum). Produces long-lasting hypothermic, neuroprotective and analgesic effects in mice following central administration in vivo.
(Modifications: Lys-1 - Lys-2 peptide bond replace with Ψ(CH2-NH))
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Lugrin et al (1991) Reduced peptide bond pseudopeptide analogues of neurotensin: binding and biological activities, and in vitro metabolic stability. Eur.J.Pharmacol. 205 191. PMID: 1812009.
Dubuc et al (1992) JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse. Eur.J.Pharmacol. 219 327. PMID: 1425958.
Torup et al (2003) Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia. Neurosci.Lett. 351 173. PMID: 14623134.
If you know of a relevant citation for this product please let us know.
View Related Products by Product Action
Keywords: JMV 449, supplier, Potent, neurotensin, receptor, agonists, NT, Receptors, JMV449, Tocris Bioscience, Neurotensin Receptor Agonists
Find multiple products by catalog number
New Products in this Area
BRS-3 antagonist; also GRPR agonistQuin C1
Potent and selective FPR2 agonistRFRP-1 (human)
Potent NPFF receptor agonistNTRC 824
Potent and selective non-peptide NTS2 antagonist
Win a $1,000 travel grant
Bio-Techne is offering 10 travel grants of $1,000 for AACR 2016.